33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.31%
Revenue growth 5-10% – Moderate. Peter Lynch would evaluate product demand drivers to determine if growth can accelerate.
9.29%
Gross profit growth 5-10% – Moderate. Peter Lynch might look at operating leverage to see if profitability can scale further.
8.01%
EBIT growth 5-10% – Moderate. Peter Lynch might look for ways the firm could optimize costs to boost EBIT further.
8.01%
Operating income growth 5-10% – Moderate. Peter Lynch would evaluate product-level profitability to see if certain segments could accelerate growth.
11.62%
Net income growth 10-15% – Solid. Seth Klarman would verify if cost control or pricing is driving consistent profit expansions.
15.38%
EPS growth 15-25% – Very strong. Benjamin Graham might verify if any one-time gains or tax benefits artificially inflate EPS.
15.38%
Diluted EPS growth 15-25% – Very strong. Benjamin Graham would verify that no large one-time items are skewing the diluted figure.
1.02%
Share count up to +3% – Slight dilution. Howard Marks would be cautious but might accept it if used for profitable growth investments.
1.02%
Diluted share count up to +3% – Modest dilution. Howard Marks might tolerate it if used for high-ROI projects or strategic acquisitions.
No Data
No Data available this quarter, please select a different quarter.
-26.15%
Negative OCF growth is a critical warning sign. Benjamin Graham would check if receivables are ballooning or if core sales are declining.
-40.72%
Negative FCF growth reveals potential liquidity pressures or large capex overshadowing cash generation. Benjamin Graham would demand deeper scrutiny.
0.52%
10Y revenue/share CAGR 0-4% – Very modest. Howard Marks would question whether the company is in a mature industry or losing competitive edge.
0.52%
5Y CAGR 0-3% – Minimal growth. Howard Marks would be cautious if the industry average is higher.
0.52%
3Y CAGR 0-2% – Almost flat. Howard Marks would worry about potential stagnation or near-term cyclical peaks.
107.97%
10Y OCF/share CAGR above 15% – Outstanding long-term cash-generation growth. Warren Buffett would check if reinvestment needs remain manageable.
107.97%
5Y OCF/share CAGR above 15% – Very robust mid-term cash expansion. Warren Buffett would check if reinvestment fosters sustainable growth.
107.97%
3Y OCF/share CAGR above 15% – Rapid short-term expansion. Warren Buffett would see if this stems from genuine operational improvements vs. working-capital swings.
11.45%
10Y net income/share CAGR 10-15% – Very strong. Warren Buffett would verify the competitive advantages that sustain these earnings expansions.
11.45%
5Y net income/share CAGR 10-15% – Very good. Warren Buffett might confirm the firm has a durable competitive edge driving consistent gains.
11.45%
3Y net income/share CAGR 10-15% – Very strong. Warren Buffett might see if this momentum is cyclical or the result of a new product edge.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
12.54%
Receivables growth 10-15% – Some buildup. Peter Lynch checks if it aligns with similar revenue expansion.
-32.82%
Negative inventory growth can boost near-term margins if sales remain stable. Benjamin Graham still checks that it’s not from falling demand.
2.76%
Asset growth 0-5% – Minimal. Howard Marks notes the firm may be optimizing existing assets or being cautious with expansions.
0.47%
0-2% annual BV/share growth – Minimal. Howard Marks worries about near-stagnant net worth accumulation.
0.49%
Debt rising up to 5% yoy – Mild increase. Peter Lynch sees expansions or acquisitions possibly justifying modest new debt.
5.97%
R&D growth 0-10% – Balanced approach. Seth Klarman sees manageable cost if new products are still in development.
2.44%
SG&A growth 0-5% – Generally manageable. Seth Klarman sees if overhead remains controlled and margins intact.